Glenmede Trust’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
Other funds holding PDLI
BIP
SPC
ECM
Glenmede Trust's PDLI Position: Q2 2020 in Review
Glenmede Trust sold out of PDL BioPharma, Inc. (PDLI) in Q2 2020, closing a stake of 206 shares.
Glenmede Trust first reported a position in PDLI in Q3 2015 and held it in 15 quarters. The position peaked at $5K in Q1 2016. 136 funds tracked by Wall St. Rank hold PDLI as of Q2 2020.
- Glenmede Trust reported no remaining PDL BioPharma, Inc. position as of Q2 2020 after selling out during the quarter.
- Glenmede Trust sold 206 PDL BioPharma, Inc. shares in Q2 2020.
- Glenmede Trust first reported a position in PDL BioPharma, Inc. in Q3 2015 and held it in 15 quarters.
- Glenmede Trust's PDL BioPharma, Inc. position peaked at $5K in Q1 2016.
- 136 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2020.
Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.